Issues related to Medicare and Medicaid drug pricing; Issues related to biosimilar access and affordability.
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Client
- AMGEN INC
- Filing UUID
- fe69cb49-562d-46ba-bc92-26082e67570d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.